Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Penicillin treatment for patients with Community-Acquired Pneumonia in Denmark: a retrospective cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Fast-track pneumonia pathway focusing on early progressive mobilisation: a clinical feasibility study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. An international perspective on hospitalized patients with viral community-acquired pneumonia

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Is chronic obstructive pulmonary disease a risk factor for death in patients with community acquired pneumonia?

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The inflamed sputum in lower respiratory tract infection: l-lactate levels are correlated to neutrophil accumulation

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Tuberculosis incidence among migrants according to migrant status: a cohort study, Denmark, 1993 to 2015

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Community-acquired pneumonia (CAP) is a severe infection, with high mortality. Antibiotic strategies for CAP differ across Europe. The objective of the study was to describe the epidemiology of CAP in Denmark and evaluate the prognosis of patients empirically treated with penicillin-G/V monotherapy.

METHODS: Retrospective cohort study including hospitalized patients with x-ray confirmed CAP. We calculated the population-based incidence, reviewed types of empiric antibiotics and duration of antibiotic treatment. We evaluated the association between mortality and treatment with empiric penicillin-G/V using logistic regression analysis.

RESULTS: We included 1320 patients. The incidence of hospitalized CAP was 3.1/1000 inhabitants. Median age was 71 years (IQR; 58-81) and in-hospital mortality was 8%. Median duration of antibiotic treatment was 10 days (IQR; 8-12). In total 45% were treated with penicillin-G/V as empiric monotherapy and they did not have a higher mortality compared to patients treated with broader-spectrum antibiotics (OR 0.92, CI 95% 0.55-1.53).

CONCLUSION: The duration of treatment exceeded recommendations in European guidelines. Empiric monotherapy with penicillin-G/V was commonly used and not associated with increased mortality in patients with mild to moderate pneumonia. Our results are in agreement with current conservative antibiotic strategy as outlined in the Danish guidelines.

Original languageEnglish
JournalBMC Pulmonary Medicine
Volume17
Issue number66
ISSN1471-2466
DOIs
Publication statusPublished - 1 Apr 2017

    Research areas

  • Journal Article

ID: 50312408